South Korea · Delayed Price · Currency is KRW Ildong Pharmaceutical Statistics
Total Valuation
KRX:249420 has a market cap or net worth of KRW 452.46 billion. The enterprise value is 525.75 billion.
| Market Cap | 452.46B |
| Enterprise Value | 525.75B |
Important Dates
The next estimated earnings date is Friday, November 13, 2026.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | Mar 30, 2026 |
Share Statistics
KRX:249420 has 31.51 million shares outstanding. The number of shares has increased by 16.74% in one year.
| Current Share Class | 31.51M |
| Shares Outstanding | 31.51M |
| Shares Change (YoY) | +16.74% |
| Shares Change (QoQ) | -0.29% |
| Owned by Insiders (%) | 2.11% |
| Owned by Institutions (%) | 3.99% |
| Float | 20.60M |
Valuation Ratios
The trailing PE ratio is 10.45.
| PE Ratio | 10.45 |
| Forward PE | n/a |
| PS Ratio | 0.78 |
| PB Ratio | 1.74 |
| P/TBV Ratio | 1.91 |
| P/FCF Ratio | 20.17 |
| P/OCF Ratio | 12.77 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.87, with an EV/FCF ratio of 23.44.
| EV / Earnings | 12.06 |
| EV / Sales | 0.90 |
| EV / EBITDA | 10.87 |
| EV / EBIT | 19.99 |
| EV / FCF | 23.44 |
Financial Position
The company has a current ratio of 1.06, with a Debt / Equity ratio of 0.50.
| Current Ratio | 1.06 |
| Quick Ratio | 0.56 |
| Debt / Equity | 0.50 |
| Debt / EBITDA | 2.75 |
| Debt / FCF | 5.85 |
| Interest Coverage | 3.07 |
Financial Efficiency
Return on equity (ROE) is 18.50% and return on invested capital (ROIC) is 6.54%.
| Return on Equity (ROE) | 18.50% |
| Return on Assets (ROA) | 2.79% |
| Return on Invested Capital (ROIC) | 6.54% |
| Return on Capital Employed (ROCE) | 7.23% |
| Weighted Average Cost of Capital (WACC) | 8.27% |
| Revenue Per Employee | 548.85M |
| Profits Per Employee | 41.10M |
| Employee Count | 1,061 |
| Asset Turnover | 1.02 |
| Inventory Turnover | 3.62 |
Taxes
In the past 12 months, KRX:249420 has paid 7.48 billion in taxes.
| Income Tax | 7.48B |
| Effective Tax Rate | 15.90% |
Stock Price Statistics
The stock price has decreased by -38.20% in the last 52 weeks. The beta is 0.89, so KRX:249420's price volatility has been lower than the market average.
| Beta (5Y) | 0.89 |
| 52-Week Price Change | -38.20% |
| 50-Day Moving Average | 15,133.00 |
| 200-Day Moving Average | 26,888.55 |
| Relative Strength Index (RSI) | 50.03 |
| Average Volume (20 Days) | 240,700 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KRX:249420 had revenue of KRW 582.33 billion and earned 43.61 billion in profits. Earnings per share was 1,373.58.
| Revenue | 582.33B |
| Gross Profit | 230.53B |
| Operating Income | 25.54B |
| Pretax Income | 47.06B |
| Net Income | 43.61B |
| EBITDA | 47.61B |
| EBIT | 25.54B |
| Earnings Per Share (EPS) | 1,373.58 |
Balance Sheet
The company has 60.37 billion in cash and 131.15 billion in debt, with a net cash position of -70.79 billion or -2,246.66 per share.
| Cash & Cash Equivalents | 60.37B |
| Total Debt | 131.15B |
| Net Cash | -70.79B |
| Net Cash Per Share | -2,246.66 |
| Equity (Book Value) | 260.45B |
| Book Value Per Share | 8,186.74 |
| Working Capital | 11.50B |
Cash Flow
In the last 12 months, operating cash flow was 35.44 billion and capital expenditures -13.01 billion, giving a free cash flow of 22.43 billion.
| Operating Cash Flow | 35.44B |
| Capital Expenditures | -13.01B |
| Depreciation & Amortization | 22.07B |
| Net Borrowing | -44.69B |
| Free Cash Flow | 22.43B |
| FCF Per Share | 711.89 |
Margins
Gross margin is 39.59%, with operating and profit margins of 4.39% and 7.49%.
| Gross Margin | 39.59% |
| Operating Margin | 4.39% |
| Pretax Margin | 8.08% |
| Profit Margin | 7.49% |
| EBITDA Margin | 8.18% |
| EBIT Margin | 4.39% |
| FCF Margin | 3.85% |
Dividends & Yields
This stock pays an annual dividend of 200.00, which amounts to a dividend yield of 1.44%.
| Dividend Per Share | 200.00 |
| Dividend Yield | 1.44% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 2 |
| Payout Ratio | 14.45% |
| Buyback Yield | -16.74% |
| Shareholder Yield | -15.30% |
| Earnings Yield | 9.64% |
| FCF Yield | 4.96% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on March 5, 2020. It was a forward split with a ratio of 1.05.
| Last Split Date | Mar 5, 2020 |
| Split Type | Forward |
| Split Ratio | 1.05 |
Scores
KRX:249420 has an Altman Z-Score of 3.23 and a Piotroski F-Score of 6.
| Altman Z-Score | 3.23 |
| Piotroski F-Score | 6 |